A ten-year period, 1966 through 1975, provided 2842 prostate specimens at The Wesley Medical Center, These specimens were classified as (1) adenocarcinoma, (2) adenosis, or (3) hyperplasia. During a follow-up period of 5--15 years (average 7.7 years), prostate carcinoma developed in seven of 108 patients (6.5%) with adenosis. During the same follow-up period prostate carcinoma developed in at least 84 of 2263 patients (3.7%) with hyperplasia. Adenosis is considered to be a dysplastic lesion because patients with histologic lesions limited to adenosis have approximately the same likelihood of prostate carcinoma developing as patients with hyperplasia.
No takes yet. Share an insight, caveat, or question.
Peter N. Brawn (1982) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: